This result therefore implicates dysregulated altSFPQ mRNA expression, along with potential translation, broadly throughout ALS, which may explain the established nuclear loss and cytoplasmic gain of SFPQ protein observed in familial and sporadic postmortem patient motor neurons (5). The gene discussed is SFPQ; the disease is amyotrophic lateral sclerosis.